What a year 2018 turned out to be for the cannabis industry. A stark increase in recreational legalizations, the incredible growth in both industry and research ventures, and the first FDA-approved cannabis-derived drug was announced. Plus much more!
In this article, we look at the support that is available to laboratories to help them adapt to the new cannabis pesticide testing requirements.
Five different plant pathogens were identified in the crown tissues of wilted plants highlighting the need for better environmental controls and cultivation practices for outdoor grows.
California's strict cannabis testing regulations may have created more problems than it has fixed.
The announcement could make Luxembourg the first European country and EU member state to fully legalize recreational cannabis for its adult residents. However, fears have been raised over a potential second black market for tourists.
Phenova, Inc. becomes the first laboratory to be awarded the accreditation for cannabis proficiency testing, filling a "significant need" within the industry.
The bill formalizes a commitment to opening a regulated medicinal cannabis scheme in the country within a year and gives those in palliative care a legal defense for using cannabis medicinally in the meantime.
We talk to Cindy Orser, PhD., about the unknown potentials and untapped molecules present within cannabis, and what this means for future exploration of the medicinal plant.
Hemp represents a tangible opportunity for future explosive market growth. Under the Farm Bill hemp cultivation will be allowed more broadly, and the product will have free movement across state borders.